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To treat and maintain the safety of patients, 
medicines should be available in adequate 
amounts, in appropriate dosage forms, and be 
affordable [1] yet studies show that this is not 
always the case and medicines shortages (MedS) 
are frequently experienced [2-5]. Whilst the 
impact of medicines shortages is noted on a 
European level [6], there is less evidence of the 
impact of these shortages on Spain as a nation. 
Notifications about medicines supply issues in 
Spain increased from 700 in 2015 to 1650 in 
2019 [7] and needs to be addressed [8]. 
Medicines shortages as a phenomenon appears 
to be a growing issue in Spain.  
To analyse the impact of medicines 
shortages on the pharmaceutical supply 
chain (PSC) as reported by pharmacists 
in Spain and to examine current 
management strategies.
The methodology involved in the study was as 
follows:
• A detailed narrative literature review was 
undertaken by the research team.
• This informed the design of a structured 
questionnaire.
• Ethical approval was granted by the Chair of 
the Biomedical, Natural, Physical and Health 
Sciences Research Ethics Panel at the 
University of Bradford.
• The questionnaire was piloted by pharmacists 
to ensure fitness for purpose for this study.
• Revisions and amendments were made to the 
questionnaire as deemed necessary.
• The final survey was circulated in 
August/September 2019 via an online link - a 
multi-channel approach channel approach was 
adopted for this. 
• Data was collated and analysed using thematic 
analysis. 
Medicines shortages are a global phenomenon which we 
(both professional and academic communities) have 
struggled to resolve. There is evidence to suggest that 
medicines shortages are on the increase in Spain as per 
recent reports by AEMPS in early 2020. 
This study reports on data that was collected in late 2019, 
within the same timeframe as the AEMPS shortages 
evaluation. The findings of this study reflect views of 271 
members of the pharmacy profession in Spain. They do 
not attempt to generalise on the MedS situation or 
professional opinion but do provide insight into 
perceptions surrounding the magnitude, impact and 
management of MedS at this time. 
Our findings show that pharmacists can be better 
supported to manage shortages through: advanced 
supply chain/inventory management training; peer 
support mechanisms; pharmacist formal and informal 
communication systems; and MedS reduction through 
more effective prevention of shortage occurrence. 
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A total of 271 pharmacists responded to this 
survey, 79% of which defined themselves as 
community pharmacists. 73% of the respondents 
had 15 years of more experience in the 
profession. 
A number of pertinent questions were posed to 
the pharmacists in this survey, the responses to a 
select number are provided in Table 1 and 
developed further in Figures 1 and 2.
A range of drugs were affected by MedS which 
led to patients not receiving treatment or in rare 
cases patient safety being compromised (Figure 
1).  
MedS caused extra work (1-2 hours/day as 
reported by 63% of the sample). 79% confirmed 
that they had suffered adverse financial 
repercussions, the impact of which was rated as 
medium by 60% and high by 24% of the group.  
Respondents said that they were aware of the 
MedS reporting systems (85%) but some were 
unsure of this. Those who were aware of it felt 
that it did not work effectively (see Table 1). 
Where policies/procedures existed (only 34%) 
guidance on how best to manage MedS
appeared to be internally driven. There was also 
evidence of external guidance from other parties. 
Figure 1: Impact of Med(S) on patients
Figure 2: Time spent by staff per working day 
managing Med(S)
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